Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress

Parallel Session 4413

Updates in Selected Cutting-Edge Topics

Wednesday, October 7, 2026
14:00 - 15:30 | TBD

This session reviews recent advances in neurodegenerative disease research, including pathology insights, Parkinson’s disease mechanisms, and neuroprotective therapy trials.

Chairs:

David Standaert, USA

Presenters:

Neuropathology of Neurodegenerative Disease During Life and at Death

Causes of Parkinson’s Disease
Seung-Jae Lee

Clinical Trials of Neuroprotective Therapies in Movement Disorders
Thomas Foltynie, United Kingdom

CSPC Liaison(s):

Ron Postuma, Canada

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Understand major advances in autopsy and biopsy studies of neurodegenerative disease
  2. Be aware of major advances in pathophysiology and mechanisms of Parkinson’s disease
  3. Identify major advances in clinical trial results of neuroprotective therapies in neurodegenerative disorders

Recommended Audience

Education Level

Advanced / Expert
Intermediate / Experienced